Congressman Bob Onder, MD (R-MO), introduced the Allergy & Asthma Patient Protection (AAPP) Act [PDF] in the US House of Representatives. The American College of Allergy, Asthma & Immunology (ACAAI) worked with Dr. Onder, a practicing allergist, to develop the bill and protect patients’ access to allergy and asthma care.

The bill addresses insurance policies that can delay or interrupt care. If passed, the legislation will help address administrative and reimbursement issues that are unique to the allergy specialty. The bill will safeguard reimbursement for essential services like allergy immunotherapy (allergy shots), reduce administrative burdens, and ensure patients maintain access to preventive allergy and asthma care that improves outcomes and lowers overall health care costs.

Specifically, the bill would:

  • Require insurers to cover allergen immunotherapy preparation consistent clinical practice;
  • Require insurers to cover clinically indicated allergy and asthma testing;
  • Prohibit insurer practices that create artificial barriers to care, including unnecessary repeat visits.

“ACAAI strongly endorses the Allergy and Asthma Patient Protection Act,” said allergists David Stukus, MD, and Cherie Zachary, MD, ACAAI’s president and immediate past president.

“Commercial insurers are increasingly restricting access to essential allergy and asthma treatments, including allergy immunotherapy, a safe and effective treatment that benefits more than 2.6 million patients annually. We thank Representative Onder, the only allergist in Congress, for introducing this important legislation to protect patient access to care and help allergists deliver the treatments their patients need.”